Overall survival (OS) analysis of the CRC cohort indicated that high expression of IL6, IL6R, IL11, IL11RA, JAK1, and STAT3 was associated with significantly poorer survival outcomes (Figure 2D). The gene discussed is IL6; the disease is colorectal carcinoma.